Free Trial

Altius Minerals Co. (TSE:ALS) Senior Officer Mark Raguz Acquires 1,400 Shares

Altius Minerals logo with Basic Materials background

Key Points

  • Mark Raguz, a Senior Officer at Altius Minerals, acquired 1,400 shares of the company at an average price of C$28.41, totaling C$39,778.20.
  • Analysts have raised their price targets for Altius Minerals, with Canaccord Genuity increasing it from C$33.00 to C$35.00 and TD Securities adjusting it from C$28.00 to C$31.00.
  • The company's stock is currently trading at C$28.90 with a market cap of C$1.34 billion, and it has a twelve-month price range between C$21.12 and C$29.69.
  • MarketBeat previews the top five stocks to own by August 1st.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Altius Minerals Co. (TSE:ALS - Get Free Report) Senior Officer Mark Raguz bought 1,400 shares of the firm's stock in a transaction that occurred on Friday, July 25th. The shares were purchased at an average cost of C$28.41 per share, with a total value of C$39,778.20.

Altius Minerals Stock Performance

ALS traded down C$0.19 during midday trading on Friday, reaching C$28.90. The company's stock had a trading volume of 116,513 shares, compared to its average volume of 87,446. The stock has a market cap of C$1.34 billion, a P/E ratio of 97.82 and a beta of 0.94. The company has a fifty day simple moving average of C$27.23 and a 200 day simple moving average of C$26.48. The company has a current ratio of 8.36, a quick ratio of 6.49 and a debt-to-equity ratio of 19.48. Altius Minerals Co. has a twelve month low of C$21.12 and a twelve month high of C$29.69.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on ALS shares. Canaccord Genuity Group increased their price target on Altius Minerals from C$33.00 to C$35.00 in a research report on Monday, April 21st. TD Securities increased their price objective on Altius Minerals from C$28.00 to C$31.00 in a research note on Wednesday, April 23rd.

Read Our Latest Research Report on Altius Minerals

About Altius Minerals

(Get Free Report)

Altius Minerals Corp is engaged in the business of obtaining diversified mining royalty. It holds interests in mining operations that produce metals and minerals such as copper, zinc, nickel, cobalt, gold, silver, and potash. The corporation also holds other pre-development stage royalty interests and various earlier stage royalties.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Altius Minerals Right Now?

Before you consider Altius Minerals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Altius Minerals wasn't on the list.

While Altius Minerals currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines